This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrowReprints and Permissions
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Dunn, J. J.
Right arrow Articles by Romero, J. R.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Dunn, J. J.
Right arrow Articles by Romero, J. R.

 Previous Article  |  Next Article 

Journal of Virology, May 2000, p. 4787-4794, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.

Genomic Determinants of Cardiovirulence in Coxsackievirus B3 Clinical Isolates: Localization to the 5' Nontranslated Region

James J. Dunn,1 Nora M. Chapman,1 Steven Tracy,1 and José R. Romero1,2,3,*

Enterovirus Research Laboratory, Department of Pathology and Microbiology, University of Nebraska Medical Center,1 Joint Division of Pediatric Infectious Diseases, Departments of Pediatrics, Creighton University and University of Nebraska Medical Center,2 and Department of Medical Microbiology and Immunology, Creighton University,3 Omaha, Nebraska

Received 7 September 1999/Accepted 4 February 2000

Coxsackievirus B3 (CVB3) infections can cause myocarditis in humans and are implicated in the pathogenesis of dilated cardiomyopathy. The natural genetic determinants of cardiovirulence for CVB3 have not been identified, although using strains engineered in the laboratory, cardiovirulence determinants have been identified in the CVB3 5' nontranslated region (5'NTR) and capsid. The myocarditic phenotypes of two CVB3 clinical isolates were determined using an established murine model of inflammatory heart disease. The 5'NTRs and capsid proteins of the noncardiovirulent CVB3/CO strain and cardiovirulent CVB3/AS strain were examined to determine their influence on the cardiovirulence phenotype. Six intratypic chimeric viruses were constructed in which 5'NTR and capsid sequences of the infectious cDNA copy of the cardiovirulent CVB3/20 genome were replaced by homologous sequences from CVB3/CO or CVB3/AS. Chimeric strains were tested for cardiovirulence by inoculation of C3H/HeJ mice. Sections of hearts removed at 10 days postinoculation were examined for evidence of myocarditis by light microscopy and assayed for the presence of virus. Replacement of the CVB3/20 capsid coding region by that from the homologous region of CVB3/CO resulted in no change in the cardiovirulent CVB3/20 phenotype, with virus recoverable from the heart at 10 days postinoculation. However, recombinant virus containing the CVB3/CO 5'NTR alone or the 5'NTR and capsid sequences together were not myocarditic, and infectious virus was not recovered from the myocardium. Chimeric viruses containing the CVB3/AS 5'NTR alone, capsid sequence alone, or both together preserved the myocarditic phenotype. These data support the 5'NTR as the primary site in the determination of the natural cardiovirulence phenotype of CVB3.

* Corresponding author. Mailing address: Joint Division of Pediatric Infectious Diseases, Creighton University, 2500 California Plaza, Criss II Rm. 409, Omaha, NE 68178. Phone: (402) 280-1235. Fax: (402) 280-1234. E-mail: jrromero{at}creighton.edu.

Journal of Virology, May 2000, p. 4787-4794, Vol. 74, No. 10
0022-538X/00/$04.00+0
Copyright © 2000, American Society for Microbiology. All rights reserved.


This article has been cited by other articles:

  • Bailey, J. M., Tapprich, W. E. (2007). Structure of the 5' Nontranslated Region of the Coxsackievirus B3 Genome: Chemical Modification and Comparative Sequence Analysis. J. Virol. 81: 650-668 [Abstract] [Full Text]  
  • Gay, R. T., Belisle, S., Beck, M. A., Meydani, S. N. (2006). An aged host promotes the evolution of avirulent coxsackievirus into a virulent strain. Proc. Natl. Acad. Sci. USA 103: 13825-13830 [Abstract] [Full Text]  
  • Kanno, T., Kim, K., Kono, K., Drescher, K. M., Chapman, N. M., Tracy, S. (2006). Group B coxsackievirus diabetogenic phenotype correlates with replication efficiency.. J. Virol. 80: 5637-5643 [Abstract] [Full Text]  
  • Dan, M., Chantler, J. K. (2005). A Genetically Engineered Attenuated Coxsackievirus B3 Strain Protects Mice against Lethal Infection. J. Virol. 79: 9285-9295 [Abstract] [Full Text]  
  • Harvala, H., Kalimo, H., Bergelson, J., Stanway, G., Hyypia, T. (2005). Tissue tropism of recombinant coxsackieviruses in an adult mouse model. J. Gen. Virol. 86: 1897-1907 [Abstract] [Full Text]  
  • Lee, C.-K., Kono, K., Haas, E., Kim, K.-S., Drescher, K. M., Chapman, N. M., Tracy, S. (2005). Characterization of an infectious cDNA copy of the genome of a naturally occurring, avirulent coxsackievirus B3 clinical isolate. J. Gen. Virol. 86: 197-210 [Abstract] [Full Text]  
  • Stadnick, E., Dan, M., Sadeghi, A., Chantler, J. K. (2004). Attenuating Mutations in Coxsackievirus B3 Map to a Conformational Epitope That Comprises the Puff Region of VP2 and the Knob of VP3. J. Virol. 78: 13987-14002 [Abstract] [Full Text]  
  • Wang, Y.-F., Chou, C.-T., Lei, H.-Y., Liu, C.-C., Wang, S.-M., Yan, J.-J., Su, I.-J., Wang, J.-R., Yeh, T.-M., Chen, S.-H., Yu, C.-K. (2004). A Mouse-Adapted Enterovirus 71 Strain Causes Neurological Disease in Mice after Oral Infection. J. Virol. 78: 7916-7924 [Abstract] [Full Text]  
  • Calabrese, F., Thiene, G. (2003). Myocarditis and inflammatory cardiomyopathy: microbiological and molecular biological aspects. Cardiovasc Res 60: 11-25 [Abstract] [Full Text]  
  • Baboonian, C., McKenna, W. (2003). Eradication of viral myocarditis: Is there hope?. J Am Coll Cardiol 42: 473-476 [Full Text]  
  • Tracy, S., Drescher, K. M., Chapman, N. M., Kim, K.-S., Carson, S. D., Pirruccello, S., Lane, P. H., Romero, J. R., Leser, J. S. (2002). Toward Testing the Hypothesis that Group B Coxsackieviruses (CVB) Trigger Insulin-Dependent Diabetes: Inoculating Nonobese Diabetic Mice with CVB Markedly Lowers Diabetes Incidence. J. Virol. 76: 12097-12111 [Abstract] [Full Text]  
  • Harvala, H., Kalimo, H., Dahllund, L., Santti, J., Hughes, P., Hyypia, T., Stanway, G. (2002). Mapping of tissue tropism determinants in coxsackievirus genomes. J. Gen. Virol. 83: 1697-1706 [Abstract] [Full Text]  
  • Feuer, R., Mena, I., Pagarigan, R., Slifka, M. K., Whitton, J. L. (2002). Cell Cycle Status Affects Coxsackievirus Replication, Persistence, and Reactivation In Vitro. J. Virol. 76: 4430-4440 [Abstract] [Full Text]  
  • Bradrick, S. S., Lieben, E. A., Carden, B. M., Romero, J. R. (2001). A Predicted Secondary Structural Domain within the Internal Ribosome Entry Site of Echovirus 12 Mediates a Cell-Type-Specific Block to Viral Replication. J. Virol. 75: 6472-6481 [Abstract] [Full Text]  
  • Wang, A., Cheung, P. K. M., Zhang, H., Carthy, C. M., Bohunek, L., Wilson, J. E., McManus, B. M., Yang, D. (2001). Specific Inhibition of Coxsackievirus B3 Translation and Replication by Phosphorothioate Antisense Oligodeoxynucleotides. Antimicrob. Agents Chemother. 45: 1043-1052 [Abstract] [Full Text]  


Copyright © 2009 by the American Society for Microbiology.   For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»